Concepedia

Second-line Immunosuppression

Second-Line Immunosuppression is a therapeutic intervention, belonging to the class of immunosuppressive strategies, specifically defined by its deployment after the failure or inadequate response to first-line immunosuppressive therapy in the management of immune-related adverse events associated with cancer immunotherapy.

27

Publications

1.3K

Citations

224

Authors

124

Institutions

Publications per year

2017–2026

14

Parents

Publications

27

Long-Term Belatacept Exposure Maintains Efficacy and Safety at 5 Years: Results From the Long-Term Extension of the BENEFIT Study

Lionel Rostaing, Flavio Vincenti, J.M. Grinyó et al. · American Journal of Transplantation · 2013 · 189 citations · Full text

, , +17

Cyclosporine vs Tacrolimus Therapy for Posterior and Intermediate Uveitis

Conor C. Murphy · Archives of Ophthalmology · 2005 · 164 citations

, , +16

Microbiome alteration via fecal microbiota transplantation is effective for refractory immune checkpoint inhibitor–induced colitis

Taylor M. Halsey, Anusha Shirwaikar Thomas, Tomo Hayase et al. · Science Translational Medicine · 2023 · 140 citations · Full text

, , +16

Idiopathic Sclerosing Orbital Inflammation

James Hsuan · Archives of Ophthalmology · 2006 · 96 citations

, , +14

Evans Syndrome in Children: Long-Term Outcome in a Prospective French National Observational Cohort

Nathalie Aladjidi, Helder Fernandes, Thierry Leblanc et al. · Frontiers in Pediatrics · 2015 · 79 citations · Full text

, , +13

1–5 of 27

Authors

224

  1. MJ
    Meghan J. Mooradian

    Massachusetts General Hospital, United States

    2 publications · 71 citations

    2

    h-index

  2. LZ
    Leyre Zubiri

    Massachusetts General Hospital, United States

    2 publications · 71 citations

    2

    h-index

  3. GE
    Gabriel E. Molina

    Massachusetts General Hospital, United States

    2 publications · 71 citations

    2

    h-index

  4. KL
    Kerry L. Reynolds

    Massachusetts General Hospital, United States

    2 publications · 71 citations

    2

    h-index

  5. MD
    Michael Dougan

    Massachusetts General Hospital, United States

    2 publications · 71 citations

    2

    h-index

1–5 of 224

Institutions

124

  1. Harvard University

    Cambridge, United States

    2 h-index

    38 publications

    1.4K citations

  2. Ludwig-Maximilians-Universität München

    Munich, Germany

    2 h-index

    6 publications

    256 citations

  3. Bellvitge University Hospital

    Barcelona, Spain

    2 h-index

    3 publications

    311 citations

  4. Inserm

    Paris, France

    2 h-index

    5 publications

    505 citations

  5. Massachusetts General Hospital

    Boston, United States

    2 h-index

    38 publications

    1.4K citations

  6. Moorfields Eye Hospital NHS Foundation Trust

    London, United Kingdom

    2 h-index

    6 publications

    148 citations

  7. University of Pennsylvania

    Philadelphia, United States

    2 h-index

    2 publications

    51 citations

  8. Hôpital Armand-Trousseau

    Paris, France

    1 h-index

    1 publications

    79 citations

1–8 of 124

Venues

  1. Archives of Ophthalmology

    2 publications · 260 citations

    2

    h-index

  2. World Journal of Clinical Cases

    WJCC · 1 publications · 19 citations

    1

    h-index

  3. Science Translational Medicine

    STM · 1 publications · 140 citations

    1

    h-index

  4. Frontiers in Pediatrics

    1 publications · 79 citations

    1

    h-index

  5. BMC Pulmonary Medicine

    1 publications · 13 citations

    1

    h-index

1–5